Venrock Healthcare Capital Partners III, L.P. Insider Profile
4 Followers
Venrock Healthcare Capital Partners III, L.P., Ten Percent Owner at Constellation Pharmaceuticals, holds 5.09M shares in KalVista Pharmaceuticals (Ticker: KALV), holds 4.15M shares in Oruka Therapeutics (Ticker: ORKA), holds 3.50M shares in Altimmune (Ticker: ALT). Most recently, Venrock Healthcare Capital Partners III, L.P. Sold ― shares of KalVista Pharmaceuticals on Mar 27, 2026 for an estimated value of $3.69M.
Venrock Healthcare Capital Partners III, L.P. Constellation Pharmaceuticals (CNST)Ten Percent Owner
Constellation Pharmaceuticals (CNST)
Ten Percent Owner
Ranked #9,088 out of 106,487 Corporate Insiders
Profitable Transactions
7 out of 18 Profitable Transactions
Average Return
+15.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Venrock Healthcare Capital Partners III, L.P.'s holdings
Insider Roles
Roles that Venrock Healthcare Capital Partners III, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 27, 2025 - Feb 27, 2026
Return:+259.90%
The most profitable trade made by Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P.'s Trading History
Constellation Pharmaceuticals
Dec 16, 2019
―
Informative Buy
13.80M
$136.53M
Altimmune
Mar 01, 2021
Ten Percent Owner
Uninformative Sell
―
$11.20M
Cogent Biosciences
Aug 18, 2020
Ten Percent Owner
Informative Buy
1.14M
$160.58M
KalVista Pharmaceuticals
Mar 27, 2026
Ten Percent Owner
Informative Sell
3.69M
$96.44M
Oruka Therapeutics
Feb 27, 2025
Ten Percent Owner
Informative Buy
1.41M
$188.59M
List of latest transactions for each holding click on a transaction to see Venrock Healthcare Capital Partners III, L.P.'s performance on stock
You May Also Like
Venrock Healthcare Capital Partners III, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Venrock Healthcare Capital Partners III, L.P.?
The percentage of profitable transactions made by Venrock Healthcare Capital Partners III, L.P. is 39%.
What is the average return per transaction made by Venrock Healthcare Capital Partners III, L.P.?
The average return per transaction made by Venrock Healthcare Capital Partners III, L.P. is 15.80%.
What stocks does Venrock Healthcare Capital Partners III, L.P. hold?
Venrock Healthcare Capital Partners III, L.P. holds: CNST, ALT, COGT, KALV, ORKA stocks.
What was Venrock Healthcare Capital Partners III, L.P.’s latest transaction?
Venrock Healthcare Capital Partners III, L.P. latest transaction was an Informative Sell of $3.69M.
What was Venrock Healthcare Capital Partners III, L.P.'s most profitable transaction?
Venrock Healthcare Capital Partners III, L.P.’s most profitable transaction was an Informative Buy of ORKA stock on February 27, 2025. The return on the trade was 259.90%.
What is Venrock Healthcare Capital Partners III, L.P.'s role in Constellation Pharmaceuticals?
Venrock Healthcare Capital Partners III, L.P.'s role in Constellation Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.